Articles

The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond.

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.

Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification before the fourth quarter of 2025.

Tjoapack Announces Packaging, Cold Chain Expansions in US and Netherlands

Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.

How Smart Technology Is Helping Reach Sustainability Goals in Drug Packaging

The company describes the compact system as ergonomically designed, providing precision dosing and production floor flexibility.

TurboFil Introduces MediFil Cart as Standalone, Servo-Controlled Ceramic Vial Filler

Richard Easton, PhD, is Technical Director–Structural Analysis, BioPharmaSpec Ltd,

Christopher Ziegenfuss is Vice President, at BioPharmaSpec, Inc

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products. 

ICH Q6B for Analytics

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.

Market Demands and Emerging Technologies Shape Outsourcing Models

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Jon Ellis and Simon Vanstone, PhD, go behind the headlines to explore the latest M&A activity and what tariffs and funding changes could mean for mRNA and beyond.

Behind the Headlines, Episode 18: Sanofi, GSK Go Big in M&A, mRNA Momentum Falters, and More

The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain.

USP Opens Advanced Technology Lab in Maryland

Cheryl Barton is director of PharmaVision, 

EMA has published recommendations to address potential radiopharmaceutical shortages.

News